LH Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-04 | 2023 | MARK S. SCHROEDER Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer | 617,635 | 0 | 1,892,720 | 718,807 | 90,506 | 3,795,108 |
| 2024-04-04 | 2023 | ANITA Z. GRAHAM Executive Vice President and Chief Human Resources Officer | 420,000 | 500,000 | 1,012,330 | 405,331 | 21,622 | 2,555,991 |
| 2024-04-04 | 2021 | BRIAN J. CAVENEY Executive Vice President and President, Early Development and Chief Medical and Scientific Officer | 521,532 | 0 | 2,122,324 | 1,034,877 | 15,851 | 3,980,629 |
| 2024-04-04 | 2022 | BRIAN J. CAVENEY Executive Vice President and President, Early Development and Chief Medical and Scientific Officer | 538,000 | 0 | 1,440,880 | 641,792 | 44,750 | 3,008,467 |
| 2024-04-04 | 2023 | BRIAN J. CAVENEY Executive Vice President and President, Early Development and Chief Medical and Scientific Officer | 617,635 | 0 | 1,745,352 | 609,719 | 70,782 | 3,476,443 |
| 2024-04-04 | 2021 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 756,287 | 0 | 3,660,580 | 1,500,695 | 43,676 | 6,458,708 |
| 2024-04-04 | 2022 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 780,500 | 0 | 6,551,496 | 661,630 | 101,879 | 8,682,493 |
| 2024-04-04 | 2023 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 805,462 | 0 | 2,473,816 | 917,054 | 144,567 | 4,956,777 |
| 2024-04-04 | 2021 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,277,381 | 0 | 13,236,819 | 3,802,068 | 432,007 | 20,551,605 |
| 2024-04-04 | 2022 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,317,500 | 0 | 9,063,244 | 1,675,221 | 729,207 | 14,927,297 |
| 2024-04-04 | 2023 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,373,692 | 0 | 9,071,320 | 2,346,018 | 938,253 | 15,979,355 |
| 2024-04-04 | 2023 | THOMAS H. PIKE Executive Vice President | 528,846 | 0 | 4,129,232 | 0 | 11,240 | 4,669,318 |
| 2024-04-04 | 2021 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 625,838 | 0 | 2,112,324 | 1,241,852 | 155,367 | 4,421,426 |
| 2024-04-04 | 2022 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 630,000 | 0 | 1,648,375 | 267,036 | 82,738 | 3,016,933 |
| 2024-04-04 | 2023 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 424,038 | 0 | 1,648,365 | 0 | 2,845,156 | 5,328,169 |
| 2024-04-04 | 2021 | MARK S. SCHROEDER Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer | 521,532 | 0 | 2,112,324 | 1,034,877 | 35,851 | 3,990,629 |
| 2024-04-04 | 2022 | MARK S. SCHROEDER Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer | 538,000 | 0 | 1,440,880 | 456,051 | 65,079 | 2,843,055 |
| 2023-03-30 | 2021 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 756,287 | 0 | 3,660,580 | 1,500,695 | 43,676 | 6,458,708 |
| 2023-03-30 | 2022 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 630,000 | 0 | 1,648,375 | 267,036 | 82,738 | 3,016,933 |
| 2023-03-30 | 2021 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 625,838 | 0 | 2,112,324 | 1,241,852 | 155,367 | 4,421,426 |
| 2023-03-30 | 2020 | MARK S. SCHROEDER Executive Vice President, and President, Diagnostics, Laboratory Operations and Global Supply Chain | 505,000 | 0 | 1,283,873 | 850,000 | 42,849 | 2,992,580 |
| 2023-03-30 | 2021 | MARK S. SCHROEDER Executive Vice President, and President, Diagnostics, Laboratory Operations and Global Supply Chain | 521,532 | 0 | 2,112,324 | 1,034,877 | 35,851 | 3,990,629 |
| 2023-03-30 | 2022 | MARK S. SCHROEDER Executive Vice President, and President, Diagnostics, Laboratory Operations and Global Supply Chain | 538,000 | 0 | 1,440,880 | 456,051 | 65,079 | 2,843,055 |
| 2023-03-30 | 2020 | PAUL R. KIRCHGRABER Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology | 606,000 | 0 | 1,283,873 | 724,608 | 66,960 | 2,973,651 |
| 2023-03-30 | 2022 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,317,500 | 0 | 9,063,244 | 1,675,221 | 729,207 | 14,927,297 |
| 2023-03-30 | 2021 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,277,381 | 0 | 13,236,819 | 3,802,068 | 432,007 | 20,551,605 |
| 2023-03-30 | 2020 | ADAM H. SCHECHTER President and Chief Executive Officer | 1,250,000 | 0 | 8,039,489 | 3,187,500 | 433,259 | 14,735,561 |
| 2023-03-30 | 2022 | BRIAN J. CAVENEY Executive Vice President, President, Diagnostics and Chief Medical Officer | 538,000 | 0 | 1,440,880 | 641,792 | 44,750 | 3,008,467 |
| 2023-03-30 | 2021 | BRIAN J. CAVENEY Executive Vice President, President, Diagnostics and Chief Medical Officer | 521,532 | 0 | 2,112,324 | 1,034,877 | 15,851 | 3,970,629 |
| 2023-03-30 | 2020 | BRIAN J. CAVENEY Executive Vice President, President, Diagnostics and Chief Medical Officer | 505,000 | 0 | 1,283,873 | 850,000 | 10,049 | 2,941,132 |
| 2023-03-30 | 2022 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 780,500 | 0 | 6,551,496 | 661,630 | 101,879 | 8,682,493 |
| 2023-03-30 | 2020 | GLENN A. EISENBERG Executive Vice President and Chief Financial Officer | 723,000 | 0 | 2,223,851 | 1,213,800 | 45,347 | 4,710,361 |
| 2022-03-31 | 2019 | ADAM H SCHECHTER Chief Executive Officer | 208,333 | 0 | 1,002,511 | 321,691 | 118,226 | 4,617,739 |
| 2022-03-31 | 2020 | PAUL R. KIRCHGRABER Executive Vice President, Chief Executive Officer, Drug Development | 606,000 | 0 | 1,283,873 | 724,608 | 66,960 | 2,973,651 |
| 2022-03-31 | 2021 | PAUL R. KIRCHGRABER Executive Vice President, Chief Executive Officer, Drug Development | 625,838 | 0 | 2,112,324 | 1,241,852 | 155,367 | 4,421,426 |
| 2022-03-31 | 2021 | ADAM H SCHECHTER Chief Executive Officer | 1,277,381 | 0 | 13,236,819 | 3,802,068 | 432,007 | 20,551,605 |
| 2022-03-31 | 2019 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 705,500 | 0 | 6,966,915 | 715,540 | 35,725 | 8,822,761 |
| 2022-03-31 | 2020 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 723,000 | 0 | 2,223,851 | 1,213,800 | 45,347 | 4,710,361 |
| 2022-03-31 | 2021 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 756,287 | 0 | 3,660,580 | 1,500,695 | 43,676 | 6,458,708 |
| 2022-03-31 | 2019 | BRIAN J. CAVENEY Executive Vice President, Diagnostics Chief Medical Officer | 462,600 | 0 | 2,542,569 | 314,274 | 9,805 | 3,449,660 |
| 2022-03-31 | 2020 | BRIAN J. CAVENEY Executive Vice President, Diagnostics Chief Medical Officer | 505,000 | 0 | 1,283,873 | 850,000 | 10,049 | 2,941,132 |
| 2022-03-31 | 2021 | BRIAN J. CAVENEY Executive Vice President, Diagnostics Chief Medical Officer | 521,532 | 0 | 2,112,324 | 1,034,877 | 15,851 | 3,970,629 |
| 2022-03-31 | 2020 | ADAM H SCHECHTER Chief Executive Officer | 1,250,000 | 0 | 8,039,489 | 3,187,500 | 433,259 | 14,735,561 |
| 2021-04-02 | 2020 | MARK S. SCHROEDER Executive Vice President, President Diagnostics, Laboratory Operations and Global Supply Chain | 723,000 | 0 | 2,223,851 | 1,213,800 | 45,347 | 4,710,361 |
| 2021-04-02 | 2019 | MARK S. SCHROEDER Executive Vice President, President Diagnostics, Laboratory Operations and Global Supply Chain | 705,500 | 0 | 6,966,915 | 715,540 | 35,725 | 8,822,761 |
| 2021-04-02 | 2018 | MARK S. SCHROEDER Executive Vice President, President Diagnostics, Laboratory Operations and Global Supply Chain | 686,662 | 0 | 1,666,134 | 621,241 | 52,955 | 3,430,739 |
| 2021-04-02 | 2020 | ADAM H. SCHECHTER Chief Executive Officer | 1,250,000 | 0 | 8,039,489 | 3,187,500 | 433,259 | 14,735,561 |
| 2021-04-02 | 2019 | ADAM H. SCHECHTER Chief Executive Officer | 208,333 | 0 | 1,002,511 | 321,691 | 118,226 | 4,617,739 |
| 2021-04-02 | 2020 | BRIAN J. CAVENEY Executive Vice President President, Diagnostics Chief Medical Officer | 505,000 | 0 | 1,283,873 | 850,000 | 10,049 | 2,941,132 |
| 2021-04-02 | 2019 | BRIAN J. CAVENEY Executive Vice President President, Diagnostics Chief Medical Officer | 462,600 | 0 | 2,542,569 | 314,274 | 9,805 | 3,449,660 |
| 2020-04-01 | 2019 | ADAM H. SCHECHTER Chief Executive Officer | 208,333 | 0 | 1,002,511 | 321,691 | 118,226 | 4,617,739 |
| 2020-04-01 | 2019 | LANCE V. BERBERIAN Executive Vice President Chief Information and Technology Officer | 507,500 | 0 | 1,675,133 | 359,311 | 9,805 | 2,703,124 |
| 2020-04-01 | 2019 | MARK S. SCHROEDER Executive Vice President, President Diagnostics Laboratory Operations and Global Supply Chain | 406,333 | 250,000 | 1,507,644 | 245,480 | 30,479 | 2,594,791 |
| 2020-04-01 | 2019 | DAVID P. KING Former Chief Executive Officer | 1,215,000 | 0 | 7,676,459 | 1,847,880 | 170,225 | 12,933,590 |
| 2020-04-01 | 2018 | DAVID P. KING Former Chief Executive Officer | 1,175,000 | 0 | 7,496,575 | 1,584,513 | 189,068 | 12,264,236 |
| 2020-04-01 | 2019 | JOHN D. RATLIFF Former Executive Vice President, Chief Executive Officer of Covance Drug Development | 582,631 | 0 | 3,199,516 | 0 | 37,326 | 4,569,469 |
| 2020-04-01 | 2017 | DAVID P. KING Former Chief Executive Officer | 1,150,000 | 0 | 6,749,173 | 1,960,367 | 75,990 | 11,646,254 |
| 2020-04-01 | 2018 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 686,662 | 0 | 1,666,134 | 621,241 | 52,955 | 3,430,739 |
| 2020-04-01 | 2017 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 666,474 | 0 | 1,588,668 | 746,219 | 33,035 | 3,407,745 |
| 2020-04-01 | 2017 | JOHN D. RATLIFF Former Executive Vice President, Chief Executive Officer of Covance Drug Development | 659,750 | 0 | 2,978,743 | 648,415 | 13,035 | 4,997,516 |
| 2020-04-01 | 2018 | JOHN D. RATLIFF Former Executive Vice President, Chief Executive Officer of Covance Drug Development | 679,750 | 0 | 5,103,644 | 762,593 | 184,961 | 7,489,637 |
| 2020-04-01 | 2019 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 705,500 | 0 | 6,966,915 | 715,540 | 35,725 | 8,822,761 |
| 2020-04-01 | 2019 | BRIAN J. CAVENEY Executive Vice President President, Diagnostics Chief Medical Officer | 462,600 | 0 | 2,542,569 | 314,274 | 9,805 | 3,479,824 |
| 2019-03-29 | 2017 | GARY M. HUFF Executive Vice President, Chief Executive Officer of LabCorp Diagnostics | 525,082 | 0 | 2,964,735 | 708,267 | 18,121 | 4,264,656 |
| 2019-03-29 | 2017 | JOHN D. RATLIFF Executive Vice President, Chief Executive Officer of Covance Drug Development | 659,750 | 0 | 2,978,743 | 648,415 | 13,035 | 4,997,516 |
| 2019-03-29 | 2018 | JOHN D. RATLIFF Executive Vice President, Chief Executive Officer of Covance Drug Development | 679,750 | 0 | 5,103,644 | 762,593 | 184,961 | 7,489,637 |
| 2019-03-29 | 2018 | GARY M. HUFF Executive Vice President, Chief Executive Officer of LabCorp Diagnostics | 600,000 | 0 | 1,249,991 | 489,330 | 2,784,825 | 5,425,847 |
| 2019-03-29 | 2016 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 653,438 | 0 | 2,799,854 | 679,626 | 10,030 | 4,142,948 |
| 2019-03-29 | 2017 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 666,474 | 0 | 1,588,668 | 746,219 | 33,035 | 3,407,745 |
| 2019-03-29 | 2018 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 686,662 | 0 | 1,666,134 | 621,241 | 52,955 | 3,430,739 |
| 2019-03-29 | 2016 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 486,875 | 0 | 529,589 | 303,833 | 12,590 | 1,359,671 |
| 2019-03-29 | 2017 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 502,125 | 0 | 475,810 | 389,204 | 14,155 | 1,528,101 |
| 2019-03-29 | 2018 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 530,000 | 0 | 499,684 | 331,139 | 14,355 | 1,494,971 |
| 2019-03-29 | 2016 | DAVID P. KING Chief Executive Officer | 1,133,333 | 0 | 7,683,109 | 1,785,419 | 149,826 | 10,853,497 |
| 2019-03-29 | 2017 | DAVID P. KING Chief Executive Officer | 1,150,000 | 0 | 6,749,173 | 1,960,367 | 75,990 | 11,646,254 |
| 2019-03-29 | 2018 | DAVID P. KING Chief Executive Officer | 1,175,000 | 0 | 7,496,575 | 1,584,513 | 189,068 | 12,264,236 |
| 2018-03-30 | 2017 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 666,474 | 0 | 1,588,668 | 746,219 | 33,035 | 3,435,987 |
| 2018-03-30 | 2015 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 444,807 | 0 | 600,318 | 236,929 | 14,590 | 1,296,644 |
| 2018-03-30 | 2016 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 486,875 | 0 | 529,589 | 303,833 | 12,590 | 1,359,671 |
| 2018-03-30 | 2017 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 502,125 | 0 | 475,810 | 389,204 | 14,155 | 1,536,524 |
| 2018-03-30 | 2015 | DAVID P. KING Chief Executive Officer | 1,044,481 | 0 | 7,878,178 | 1,672,371 | 31,384 | 3,407,745 |
| 2018-03-30 | 2016 | DAVID P. KING Chief Executive Officer | 1,133,333 | 0 | 7,683,109 | 1,785,419 | 149,826 | 1,528,101 |
| 2018-03-30 | 2017 | DAVID P. KING Chief Executive Officer | 1,150,000 | 0 | 6,749,173 | 1,960,367 | 75,990 | 11,646,254 |
| 2018-03-30 | 2017 | JOHN D. RATLIFF Executive Vice President, Chief Executive Officer of Covance Drug Development | 659,750 | 0 | 2,978,743 | 648,415 | 13,035 | 4,997,516 |
| 2018-03-30 | 2017 | GARY M. HUFF Executive Vice President, Chief Executive Officer of LabCorp Diagnostics | 525,082 | 0 | 2,964,735 | 708,267 | 18,121 | 4,264,656 |
| 2018-03-30 | 2015 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 635,417 | 0 | 2,110,929 | 676,912 | 22,565 | 3,445,823 |
| 2018-03-30 | 2016 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 653,438 | 0 | 2,799,854 | 679,626 | 10,030 | 4,142,948 |
| 2017-03-31 | 2016 | LISA J. UTHGENANNT Senior Vice President Chief Human Resources Officer | 440,171 | 0 | 614,120 | 318,912 | 11,762 | 1,384,965 |
| 2017-03-31 | 2014 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 436,085 | 0 | 572,834 | 230,412 | 17,083 | 1,331,146 |
| 2017-03-31 | 2015 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 444,807 | 0 | 600,318 | 236,929 | 14,590 | 1,296,644 |
| 2017-03-31 | 2016 | DEBORAH L. KELLER Former Executive Vice President, Chief Executive Officer of Covance Drug Development | 474,041 | 0 | 1,397,304 | 637,216 | 1,324,684 | 3,837,790 |
| 2017-03-31 | 2014 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 338,542 | 0 | 3,946,320 | 344,553 | 9,083 | 4,638,498 |
| 2017-03-31 | 2015 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 635,417 | 0 | 2,110,929 | 676,912 | 22,565 | 3,445,823 |
| 2017-03-31 | 2016 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 653,438 | 0 | 2,799,854 | 679,626 | 10,030 | 4,142,948 |
| 2017-03-31 | 2016 | DAVID P. KING Chief Executive Officer | 1,133,333 | 0 | 7,683,109 | 1,785,419 | 149,826 | 10,853,497 |
| 2017-03-31 | 2015 | DAVID P. KING Chief Executive Officer | 1,044,481 | 0 | 7,878,178 | 1,672,371 | 31,384 | 10,626,414 |
| 2017-03-31 | 2014 | DAVID P. KING Chief Executive Officer | 1,013,000 | 0 | 7,538,153 | 1,600,450 | 25,723 | 10,472,562 |
| 2017-03-31 | 2016 | LANCE V. BERBERIAN Senior Vice President Chief Information Officer | 396,112 | 0 | 1,396,438 | 205,993 | 9,940 | 2,008,483 |
| 2017-03-31 | 2015 | LANCE V. BERBERIAN Senior Vice President Chief Information Officer | 373,625 | 0 | 519,977 | 199,012 | 20,312 | 1,112,926 |
| 2017-03-31 | 2016 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 486,875 | 0 | 529,589 | 303,833 | 12,590 | 1,359,671 |
| 2016-04-01 | 2013 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 371,529 | 0 | 491,909 | 109,774 | 13,252 | 986,464 |
| 2016-04-01 | 2015 | JOSEPH E. HERRING Former Executive Vice President Chief Executive Officer, Covance Drug Development | 583,333 | 0 | 2,456,771 | 743,276 | 0 | 3,783,380 |
| 2016-04-01 | 2015 | DAVID P. KING Chief Executive Officer | 1,044,481 | 0 | 7,878,178 | 1,672,371 | 31,384 | 10,626,414 |
| 2016-04-01 | 2014 | DAVID P. KING Chief Executive Officer | 1,013,000 | 0 | 7,538,153 | 1,600,450 | 25,723 | 10,472,562 |
| 2016-04-01 | 2013 | DAVID P. KING Chief Executive Officer | 1,013,000 | 0 | 7,450,735 | 790,594 | 26,667 | 9,280,996 |
| 2016-04-01 | 2015 | LANCE V. BERBERIAN Senior Vice President Chief Information Officer | 373,625 | 0 | 519,977 | 199,012 | 20,312 | 1,112,926 |
| 2016-04-01 | 2015 | JAMES T. BOYLE, JR. Executive Vice President Chief Executive Officer, LabCorp Diagnostics | 645,263 | 0 | 3,832,755 | 925,701 | 25,170 | 5,428,889 |
| 2016-04-01 | 2014 | JAMES T. BOYLE, JR. Executive Vice President Chief Executive Officer, LabCorp Diagnostics | 632,611 | 0 | 3,666,518 | 835,621 | 25,511 | 5,294,774 |
| 2016-04-01 | 2013 | JAMES T. BOYLE, JR. Executive Vice President Chief Executive Officer, LabCorp Diagnostics | 587,200 | 0 | 3,554,850 | 404,931 | 22,236 | 4,569,217 |
| 2016-04-01 | 2015 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 444,807 | 0 | 600,318 | 236,929 | 14,590 | 1,296,644 |
| 2016-04-01 | 2014 | F. SAMUEL EBERTS III Senior Vice President Chief Legal Officer | 436,085 | 0 | 572,834 | 230,412 | 17,083 | 1,331,146 |
| 2016-04-01 | 2015 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 635,417 | 0 | 2,110,929 | 676,912 | 22,565 | 3,445,823 |
| 2016-04-01 | 2014 | GLENN A. EISENBERG Executive Vice President Chief Financial Officer | 338,542 | 0 | 3,946,320 | 344,553 | 9,083 | 4,638,498 |
| 2015-04-03 | 2012 | James T. Boyle, Jr. Executive Vice President Chief Operating Officer | 511,900 | 0 | 1,695,335 | 0 | 0 | 3,558,545 |
| 2015-04-03 | 2014 | Mark E. Brecher Chief Medical Officer | 352,165 | 0 | 507,791 | 0 | 0 | 1,065,924 |
| 2015-04-03 | 2014 | William B. Hayes Former Executive Vice President Chief Financial Officer | 277,234 | 0 | 855,641 | 0 | 0 | 1,612,359 |
| 2015-04-03 | 2013 | William B. Hayes Former Executive Vice President Chief Financial Officer | 477,833 | 0 | 2,537,031 | 0 | 0 | 3,289,354 |
| 2015-04-03 | 2012 | William B. Hayes Former Executive Vice President Chief Financial Officer | 469,961 | 0 | 1,686,254 | 0 | 0 | 3,373,901 |
| 2015-04-03 | 2014 | Glenn A. Eisenberg | 338,542 | 0 | 3,946,320 | 0 | 0 | 4,638,498 |
| 2015-04-03 | 2012 | F. Samuel Eberts III Senior Vice President Chief Legal Officer | 346,929 | 0 | 331,672 | 0 | 0 | 993,118 |
| 2015-04-03 | 2014 | David P. King Chief Executive Officer | 1,013,000 | 0 | 7,538,153 | 0 | 0 | 10,472,562 |
| 2015-04-03 | 2013 | David P. King Chief Executive Officer | 1,013,000 | 0 | 7,450,735 | 0 | 0 | 9,280,996 |
| 2015-04-03 | 2014 | James T. Boyle, Jr. Executive Vice President Chief Operating Officer | 632,611 | 0 | 3,666,518 | 0 | 0 | 5,294,774 |
| 2015-04-03 | 2013 | James T. Boyle, Jr. Executive Vice President Chief Operating Officer | 587,200 | 0 | 3,554,850 | 0 | 0 | 4,569,217 |
| 2015-04-03 | 2013 | F. Samuel Eberts III Senior Vice President Chief Legal Officer | 371,529 | 0 | 491,909 | 0 | 0 | 986,464 |
| 2015-04-03 | 2013 | Mark E. Brecher Chief Medical Officer | 345,260 | 0 | 491,909 | 0 | 0 | 964,277 |
| 2015-04-03 | 2014 | F. Samuel Eberts III Senior Vice President Chief Legal Officer | 436,085 | 0 | 572,834 | 0 | 0 | 1,331,146 |
| 2014-04-04 | 2012 | F. Samuel Eberts III Senior Vice President | 346,929 | 0 | 331,672 | 116,734 | 12,423 | 993,118 |
| 2014-04-04 | 2013 | David P. King Chief Executive Officer | 1,013,000 | 0 | 7,450,735 | 790,594 | 26,667 | 9,280,996 |
| 2014-04-04 | 2012 | David P. King Chief Executive Officer | 1,012,700 | 0 | 5,288,813 | 1,056,872 | 24,402 | 9,693,761 |
| 2014-04-04 | 2011 | David P. King Chief Executive Officer | 993,800 | 0 | 4,546,074 | 2,019,536 | 25,660 | 11,058,998 |
| 2014-04-04 | 2013 | Mark E. Brecher | 345,260 | 0 | 491,909 | 107,435 | 19,973 | 964,577 |
| 2014-04-04 | 2013 | James T. Boyle Executive Vice President Chief Operating Officer | 587,200 | 0 | 3,554,850 | 404,931 | 22,236 | 4,569,217 |
| 2014-04-04 | 2012 | James T. Boyle Executive Vice President Chief Operating Officer | 511,900 | 0 | 1,695,335 | 430,605 | 23,427 | 3,558,545 |
| 2014-04-04 | 2011 | James T. Boyle Executive Vice President Chief Operating Officer | 501,900 | 0 | 1,460,914 | 803,421 | 27,489 | 3,941,273 |
| 2014-04-04 | 2013 | F. Samuel Eberts III Senior Vice President | 371,529 | 0 | 491,909 | 109,774 | 13,252 | 986,464 |
| 2014-04-04 | 2013 | William B. Hayes Executive Vice President Chief Financial Officer | 477,833 | 0 | 2,537,031 | 249,431 | 25,059 | 3,289,354 |
| 2014-04-04 | 2012 | William B. Hayes Executive Vice President Chief Financial Officer | 469,961 | 0 | 1,686,254 | 292,725 | 24,372 | 3,373,901 |
| 2014-04-04 | 2011 | William B. Hayes Executive Vice President Chief Financial Officer | 465,151 | 0 | 1,442,766 | 629,321 | 26,350 | 3,760,066 |
| 2013-03-28 | 2011 | James T. Boyle Executive Vice President Chief Operating Officer | 501,900 | 0 | 1,460,914 | 803,421 | 27,489 | 3,941,273 |
| 2013-03-28 | 2012 | James T. Boyle Executive Vice President Chief Operating Officer | 511,900 | 0 | 1,695,335 | 430,605 | 23,427 | 3,558,545 |
| 2013-03-28 | 2010 | David P. King Chief Executive Officer | 885,333 | 0 | 4,040,640 | 1,902,675 | 59,287 | 9,672,746 |
| 2013-03-28 | 2011 | David P. King Chief Executive Officer | 993,800 | 0 | 4,546,074 | 2,019,536 | 25,660 | 11,058,998 |
| 2013-03-28 | 2012 | David P. King Chief Executive Officer | 1,012,700 | 0 | 5,288,813 | 1,056,872 | 24,402 | 9,693,761 |
| 2013-03-28 | 2012 | Lidia L. Fonseca Senior Vice President Chief Information Officer | 349,298 | 0 | 331,672 | 141,036 | 10,003 | 1,004,836 |
| 2013-03-28 | 2010 | William B. Hayes Executive Vice President Chief Financial Officer | 436,800 | 0 | 1,367,925 | 589,490 | 52,331 | 3,443,769 |
| 2013-03-28 | 2011 | William B. Hayes Executive Vice President Chief Financial Officer | 465,151 | 0 | 1,442,766 | 629,321 | 26,350 | 3,760,066 |
| 2013-03-28 | 2012 | F. Samuel Eberts III Senior Vice President Chief Legal Officer | 346,929 | 0 | 331,672 | 116,734 | 12,423 | 993,118 |
| 2013-03-28 | 2010 | James T. Boyle Executive Vice President Chief Operating Officer | 450,000 | 0 | 1,725,175 | 702,782 | 64,488 | 3,860,882 |
| 2013-03-28 | 2012 | William B. Hayes Executive Vice President Chief Financial Officer | 469,961 | 0 | 1,686,254 | 292,725 | 24,372 | 3,373,901 |
| 2013-03-28 | 2011 | Lidia L. Fonseca Senior Vice President Chief Information Officer | 344,687 | 0 | 299,442 | 278,723 | 21,350 | 1,174,309 |
| 2012-03-20 | 2010 | William B. Hayes Executive Vice President and Chief Financial Officer | 436,800 | 0 | 1,367,925 | 589,490 | 52,331 | 3,443,769 |
| 2012-03-20 | 2011 | David P. King Chief Executive Officer | 993,800 | 0 | 4,546,074 | 2,019,536 | 25,660 | 11,058,998 |
| 2012-03-20 | 2010 | David P. King Chief Executive Officer | 885,333 | 0 | 4,040,640 | 1,902,675 | 59,287 | 9,672,746 |
| 2012-03-20 | 2009 | David P. King Chief Executive Officer | 810,000 | 0 | 4,034,688 | 1,422,384 | 46,869 | 8,938,814 |
| 2012-03-20 | 2011 | James T. Boyle Chief Operating Officer | 501,900 | 0 | 1,460,914 | 803,421 | 27,489 | 3,941,273 |
| 2012-03-20 | 2010 | James T. Boyle Chief Operating Officer | 450,000 | 0 | 1,725,175 | 702,782 | 64,488 | 3,860,882 |
| 2012-03-20 | 2011 | Lidia L. Fonseca Senior Vice President, Chief Information Officer | 344,687 | 0 | 299,442 | 278,723 | 21,350 | 1,174,309 |
| 2012-03-20 | 2011 | William B. Hayes Executive Vice President and Chief Financial Officer | 465,151 | 0 | 1,442,766 | 629,321 | 26,350 | 3,760,066 |
| 2012-03-20 | 2009 | William B. Hayes Executive Vice President and Chief Financial Officer | 419,333 | 0 | 1,476,984 | 577,496 | 46,094 | 3,501,409 |
| 2012-03-20 | 2011 | Andrew S. Walton Executive Vice President | 368,778 | 0 | 780,364 | 437,005 | 19,385 | 2,208,608 |
| 2012-03-20 | 2010 | Andrew S. Walton Executive Vice President | 347,200 | 0 | 750,605 | 412,682 | 50,799 | 2,077,915 |
| 2012-03-20 | 2009 | Andrew S. Walton Executive Vice President | 335,000 | 24,750 | 768,512 | 290,077 | 43,474 | 1,950,458 |
| 2011-03-31 | 2010 | Andrew S. Walton Executive Vice President | 347,200 | 0 | 750,605 | 412,682 | 50,799 | 2,077,915 |
| 2011-03-31 | 2008 | William B. Hayes Executive Vice President and Chief Financial Officer | 413,333 | 55,000 | 1,529,500 | 87,336 | 45,764 | 3,068,401 |
| 2011-03-31 | 2009 | William B. Hayes Executive Vice President and Chief Financial Officer | 419,333 | 0 | 1,476,984 | 577,496 | 46,094 | 3,501,409 |
| 2011-03-31 | 2010 | William B. Hayes Executive Vice President and Chief Financial Officer | 436,800 | 0 | 1,367,925 | 589,490 | 52,331 | 3,443,769 |
| 2011-03-31 | 2010 | Andrew J. Conrad | 423,667 | 0 | 820,755 | 538,002 | 26,247 | 2,350,366 |
| 2011-03-31 | 2010 | James T. Boyle | 450,000 | 0 | 1,725,175 | 702,782 | 64,488 | 3,860,882 |
| 2011-03-31 | 2008 | David P. King Chief Executive Officer | 791,667 | 160,000 | 4,145,750 | 605,674 | 45,751 | 8,296,955 |
| 2011-03-31 | 2009 | David P. King Chief Executive Officer | 810,000 | 0 | 4,034,688 | 1,422,384 | 46,869 | 8,938,814 |
| 2011-03-31 | 2009 | Andrew S. Walton Executive Vice President | 335,000 | 24,750 | 768,512 | 290,077 | 43,474 | 1,950,458 |
| 2011-03-31 | 2010 | David P. King Chief Executive Officer | 885,333 | 0 | 4,040,640 | 1,902,675 | 59,287 | 9,672,746 |
| 2010-04-01 | 2009 | Andrew S. Walton | 335,000 | 24,750 | 768,512 | 290,077 | 43,474 | 1,950,458 |
| 2010-04-01 | 2009 | David P. King Chief Executive Officer | 810,000 | 0 | 4,034,688 | 1,422,384 | 46,869 | 8,938,814 |
| 2010-04-01 | 2008 | David P. King Chief Executive Officer | 791,667 | 160,000 | 4,145,750 | 605,674 | 45,751 | 8,296,955 |
| 2010-04-01 | 2007 | David P. King Chief Executive Officer | 750,000 | 0 | 2,006,500 | 1,464,696 | 50,491 | 6,522,534 |
| 2010-04-01 | 2009 | Don M. Hardison Chief Operating Officer | 466,938 | 0 | 1,693,128 | 556,610 | 1,148,077 | 4,963,553 |
| 2010-04-01 | 2008 | Don M. Hardison Chief Operating Officer | 478,750 | 100,000 | 1,851,500 | 188,462 | 34,576 | 3,808,327 |
| 2010-04-01 | 2009 | William B. Hayes Executive Vice President and Chief Financial Officer | 419,333 | 0 | 1,476,984 | 577,496 | 46,094 | 3,501,409 |
| 2010-04-01 | 2008 | William B. Hayes Executive Vice President and Chief Financial Officer | 413,333 | 55,000 | 1,529,500 | 87,336 | 45,764 | 3,068,401 |
| 2010-04-01 | 2007 | William B. Hayes Executive Vice President and Chief Financial Officer | 391,667 | 0 | 1,103,575 | 437,303 | 46,921 | 2,807,462 |
| 2010-04-01 | 2009 | F. Samuel Eberts III | 311,643 | 0 | 294,196 | 177,588 | 27,856 | 1,052,940 |
| 2009-03-24 | 2008 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer and Medical Director | 401,348 | 51,000 | 1,414,368 | 125,078 | 42,342 | 3,018,760 |
| 2009-03-24 | 2007 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer and Medical Director | 385,601 | 0 | 1,559,843 | 328,188 | 36,817 | 3,017,710 |
| 2009-03-24 | 2008 | William B. Haas Executive Vice President Esoteric Business | 146,479 | 0 | 1,821,807 | 111,563 | 496,406 | 3,473,553 |
| 2009-03-24 | 2007 | William B. Haas Executive Vice President Esoteric Business | 341,171 | 0 | 1,033,720 | 297,069 | 46,702 | 2,238,561 |
| 2009-03-24 | 2008 | David P. King Chief Executive Officer | 791,667 | 160,000 | 2,007,153 | 605,674 | 45,751 | 5,226,496 |
| 2009-03-24 | 2007 | David P. King Chief Executive Officer | 750,000 | 0 | 1,772,508 | 1,464,696 | 50,491 | 5,147,207 |
| 2009-03-24 | 2006 | David P. King Chief Executive Officer | 450,003 | 0 | 885,404 | 642,094 | 44,722 | 2,626,343 |
| 2009-03-24 | 2008 | William B. Hayes Executive Vice President and Chief Financial Officer | 413,333 | 55,000 | 1,174,457 | 87,336 | 45,764 | 2,426,546 |
| 2009-03-24 | 2007 | William B. Hayes Executive Vice President and Chief Financial Officer | 391,667 | 0 | 1,503,886 | 437,303 | 46,291 | 2,912,449 |
| 2009-03-24 | 2006 | William B. Hayes Executive Vice President and Chief Financial Officer | 350,002 | 0 | 813,831 | 431,063 | 49,194 | 2,004,576 |
| 2009-03-24 | 2008 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 558,333 | 98,000 | 2,479,439 | 260,294 | 46,796 | 6,982,353 |
| 2009-03-24 | 2007 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 540,000 | 0 | 2,317,826 | 825,492 | 45,953 | 5,060,593 |
| 2009-03-24 | 2006 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 453,863 | 0 | 1,338,537 | 595,877 | 33,736 | 3,704,152 |
| 2009-03-24 | 2008 | Don M. Hardison | 478,750 | 100,000 | 749,363 | 188,462 | 34,576 | 2,014,508 |
| 2008-03-25 | 2006 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 453,863 | 0 | 1,338,537 | 595,877 | 33,736 | 3,704,152 |
| 2008-03-25 | 2007 | William B. Haas Executive Vice President Esoteric Business | 341,171 | 0 | 1,033,720 | 297,069 | 46,702 | 2,238,561 |
| 2008-03-25 | 2007 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer and Medical Director | 385,601 | 0 | 1,559,843 | 328,188 | 36,817 | 3,017,710 |
| 2008-03-25 | 2006 | William B. Hayes Executive Vice President and Chief Financial Officer | 350,002 | 0 | 813,831 | 431,063 | 49,194 | 2,004,576 |
| 2008-03-25 | 2007 | William B. Hayes Executive Vice President and Chief Financial Officer | 391,667 | 0 | 1,503,886 | 437,303 | 46,291 | 2,912,449 |
| 2008-03-25 | 2006 | David P. King Chief Executive Officer | 450,003 | 0 | 885,404 | 642,094 | 44,722 | 2,626,343 |
| 2008-03-25 | 2007 | David P. King Chief Executive Officer | 750,000 | 0 | 1,772,508 | 1,464,696 | 50,491 | 5,147,207 |
| 2008-03-25 | 2007 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 540,000 | 0 | 2,317,826 | 825,492 | 45,953 | 5,060,593 |
| 2007-04-17 | 2006 | William B. Hayes Executive Vice President and Chief Financial Officer | 350,002 | 0 | 813,831 | 431,063 | 49,194 | 2,004,576 |
| 2007-04-17 | 2006 | Richard L. Novak Executive Vice President, Strategic Planning | 524,960 | 0 | 4,125,393 | 850,575 | 53,727 | 7,763,617 |
| 2007-04-17 | 2006 | Thomas P. Mac Mahon Chairman and Chief Executive Officer | 989,526 | 0 | 12,441,575 | 2,041,500 | 67,649 | 21,508,873 |
| 2007-04-17 | 2006 | Bradford T. Smith Executive Vice President and Chief Legal Officer | 453,863 | 0 | 1,338,537 | 595,877 | 47,595 | 3,524,327 |
| 2007-04-17 | 2006 | David P. King Executive Vice President and Chief Operating Officer | 450,003 | 0 | 885,404 | 642,094 | 44,722 | 2,626,343 |
| 2006-04-14 | 2004 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 416,950 | 518,774 | 0 | 0 | 0 | 935,724 |
| 2006-04-14 | 2005 | Thomas P. Mac Mahon President and Chief Executive Officer | 929,688 | 1,322,113 | 1,929,967 | 0 | 0 | 4,181,768 |
| 2006-04-14 | 2004 | Thomas P. Mac Mahon President and Chief Executive Officer | 885,375 | 1,586,654 | 0 | 0 | 0 | 2,472,029 |
| 2006-04-14 | 2003 | Thomas P. Mac Mahon President and Chief Executive Officer | 845,625 | 1,297,910 | 0 | 0 | 0 | 2,143,535 |
| 2006-04-14 | 2005 | Richard L. Novak Executive Vice President of Strategic Planning and Corporate Development | 505,695 | 542,315 | 633,345 | 0 | 0 | 1,681,355 |
| 2006-04-14 | 2004 | Richard L. Novak Executive Vice President of Strategic Planning and Corporate Development | 483,110 | 603,018 | 0 | 0 | 0 | 1,086,128 |
| 2006-04-14 | 2003 | Richard L. Novak Executive Vice President of Strategic Planning and Corporate Development | 469,040 | 571,709 | 0 | 0 | 0 | 1,040,749 |
| 2006-04-14 | 2005 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 437,500 | 444,059 | 514,818 | 0 | 0 | 1,396,377 |
| 2006-04-14 | 2003 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 399,750 | 458,321 | 0 | 0 | 0 | 858,071 |
| 2006-04-14 | 2005 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 357,678 | 302,706 | 402,276 | 0 | 0 | 1,062,660 |
| 2006-04-14 | 2004 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 341,436 | 311,388 | 0 | 0 | 0 | 652,824 |
| 2006-04-14 | 2003 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 326,733 | 262,579 | 0 | 0 | 0 | 589,312 |
| 2006-04-14 | 2005 | David P. King Executive Vice President and Chief Operating Officer | 340,999 | 216,697 | 402,276 | 0 | 0 | 959,972 |
| 2006-04-14 | 2004 | David P. King Executive Vice President and Chief Operating Officer | 309,999 | 174,242 | 0 | 0 | 0 | 484,241 |
| 2006-04-14 | 2003 | David P. King Executive Vice President and Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2005-04-15 | 2002 | Thomas P. Mac Mahon President and Chief Executive Officer | 825,000 | 1,463,671 | 14,159,036 | 0 | 0 | 16,447,707 |
| 2005-04-15 | 2004 | Richard L. Novak Executive Vice President and Chief Operating Officer | 483,110 | 603,018 | 0 | 0 | 0 | 1,086,128 |
| 2005-04-15 | 2003 | Richard L. Novak Executive Vice President and Chief Operating Officer | 469,040 | 571,709 | 0 | 0 | 0 | 1,040,749 |
| 2005-04-15 | 2002 | Richard L. Novak Executive Vice President and Chief Operating Officer | 454,667 | 647,919 | 6,653,110 | 0 | 0 | 7,755,696 |
| 2005-04-15 | 2004 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 416,950 | 518,774 | 0 | 0 | 0 | 935,724 |
| 2005-04-15 | 2003 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 399,750 | 458,321 | 0 | 0 | 0 | 858,071 |
| 2005-04-15 | 2002 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 387,500 | 503,623 | 5,155,072 | 0 | 0 | 6,046,195 |
| 2005-04-15 | 2004 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 416,950 | 500,002 | 0 | 0 | 0 | 916,952 |
| 2005-04-15 | 2003 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 399,750 | 424,236 | 0 | 0 | 0 | 823,986 |
| 2005-04-15 | 2002 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 387,500 | 480,763 | 5,155,072 | 0 | 0 | 6,023,335 |
| 2005-04-15 | 2004 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 341,436 | 311,388 | 0 | 0 | 0 | 652,824 |
| 2005-04-15 | 2003 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 326,733 | 262,579 | 0 | 0 | 0 | 589,312 |
| 2005-04-15 | 2002 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 299,667 | 271,920 | 2,468,548 | 0 | 0 | 3,040,135 |
| 2005-04-15 | 2004 | Thomas P. Mac Mahon President and Chief Executive Officer | 885,375 | 1,586,654 | 0 | 0 | 0 | 2,472,029 |
| 2005-04-15 | 2003 | Thomas P. Mac Mahon President and Chief Executive Officer | 845,625 | 1,297,910 | 0 | 0 | 0 | 2,143,535 |
| 2004-04-13 | 2002 | Richard L. Novak Executive Vice President and Chief Operating Officer | 454,667 | 647,919 | 6,653,110 | 0 | 0 | 7,755,696 |
| 2004-04-13 | 2002 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 387,500 | 480,763 | 5,155,072 | 0 | 0 | 6,023,335 |
| 2004-04-13 | 2001 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 365,833 | 573,576 | 1,587,000 | 0 | 0 | 2,526,409 |
| 2004-04-13 | 2003 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 326,733 | 262,579 | 0 | 0 | 0 | 589,312 |
| 2004-04-13 | 2002 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 299,667 | 271,920 | 2,468,548 | 0 | 0 | 3,040,135 |
| 2004-04-13 | 2001 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 285,000 | 298,706 | 595,125 | 0 | 0 | 1,178,831 |
| 2004-04-13 | 2001 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 365,833 | 532,554 | 1,587,000 | 0 | 0 | 2,485,387 |
| 2004-04-13 | 2002 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 387,500 | 503,623 | 5,155,072 | 0 | 0 | 6,046,195 |
| 2004-04-13 | 2003 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 399,750 | 458,321 | 0 | 0 | 0 | 858,071 |
| 2004-04-13 | 2001 | Richard L. Novak Executive Vice President and Chief Operating Officer | 433,333 | 691,728 | 1,983,750 | 0 | 0 | 3,108,811 |
| 2004-04-13 | 2003 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 399,750 | 424,236 | 0 | 0 | 0 | 823,986 |
| 2004-04-13 | 2003 | Richard L. Novak Executive Vice President and Chief Operating Officer | 469,040 | 571,709 | 0 | 0 | 0 | 1,040,749 |
| 2004-04-13 | 2001 | Thomas P. Mac Mahon President and Chief Executive Officer | 812,500 | 1,850,295 | 4,906,475 | 0 | 0 | 7,569,270 |
| 2004-04-13 | 2002 | Thomas P. Mac Mahon President and Chief Executive Officer | 825,000 | 1,463,671 | 14,159,036 | 0 | 0 | 16,447,707 |
| 2004-04-13 | 2003 | Thomas P. Mac Mahon President and Chief Executive Officer | 845,625 | 1,297,910 | 0 | 0 | 0 | 2,143,535 |
| 2003-04-14 | 2002 | Thomas P. Mac Mahon President and Chief Executive Officer | 825,000 | 1,463,671 | 14,159,036 | 0 | 0 | 16,447,707 |
| 2003-04-14 | 2001 | Thomas P. Mac Mahon President and Chief Executive Officer | 812,500 | 1,850,295 | 4,906,475 | 0 | 0 | 7,569,270 |
| 2003-04-14 | 2000 | Thomas P. Mac Mahon President and Chief Executive Officer | 741,667 | 726,311 | 3,462,344 | 0 | 0 | 4,930,322 |
| 2003-04-14 | 2002 | Richard L. Novak Executive Vice President and Chief Operating Officer | 454,667 | 647,919 | 6,653,110 | 0 | 0 | 7,755,696 |
| 2003-04-14 | 2000 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 313,333 | 254,400 | 758,300 | 0 | 0 | 1,326,033 |
| 2003-04-14 | 2002 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 387,500 | 503,623 | 5,155,072 | 0 | 0 | 6,046,195 |
| 2003-04-14 | 2001 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 365,833 | 532,554 | 1,587,000 | 0 | 0 | 2,485,387 |
| 2003-04-14 | 2000 | Bradford T. Smith Executive Vice President, Chief Legal Officer, and Secretary | 313,333 | 245,400 | 758,300 | 0 | 0 | 1,317,033 |
| 2003-04-14 | 2002 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 299,667 | 271,920 | 2,468,548 | 0 | 0 | 3,040,135 |
| 2003-04-14 | 2001 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 285,000 | 298,706 | 595,125 | 0 | 0 | 1,178,831 |
| 2003-04-14 | 2000 | Myla P. Lai-Goldman Executive Vice President, Chief Scientific Officer, and Medical Director | 256,667 | 209,381 | 388,625 | 0 | 0 | 854,673 |
| 2003-04-14 | 2001 | Richard L. Novak Executive Vice President and Chief Operating Officer | 433,333 | 691,728 | 1,983,750 | 0 | 0 | 3,108,811 |
| 2003-04-14 | 2000 | Richard L. Novak Executive Vice President and Chief Operating Officer | 391,667 | 427,200 | 1,695,219 | 0 | 0 | 2,514,086 |
| 2003-04-14 | 2002 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 387,500 | 480,763 | 5,155,072 | 0 | 0 | 6,023,335 |
| 2003-04-14 | 2001 | Wesley R. Elingburg Executive Vice President, Chief Financial Officer, and Treasurer | 365,833 | 573,576 | 1,587,000 | 0 | 0 | 2,526,409 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
